Close

Athenex, Inc. Announces Second Quarter 2019 Financial Results, Positive Phase III Results on Oral Paclitaxel plus Encequidar and Increased Product Sales Guidance Aug 7, 2019 06:00AM
Athenex, Inc. Announces Second Quarter 2019 Financial Results, Positive Phase III Results on Oral Paclitaxel plus Encequidar and Increased Product Sales Guidance Aug 7, 2019 06:00AM
Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update May 9, 2019 07:00AM
Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update May 9, 2019 07:00AM
Athenex (ATNX) Announces $100 Million Private Placement of Common Stock May 6, 2019 08:11AM


May 6, 2019 08:00AM Athenex Announces $100 Million Private Placement
May 6, 2019 08:00AM Athenex Announces $100 Million Private Placement